Centre René Gauducheau

corporate_fareorganization

Centre René Gauducheau

- Funding / Projects
  (73)

73 Projects, page 1 of 15

Bevacizumab intra-artériel hépatique et chimiothérapie systémique dans les métastases hépatiques de cancer colorectal métastatasé : étude de phase II multicentrique chez des patients en progression après chimiothérapie systémique de première ligne. Hepatic arterial bevacizumab plus systemic chemotherapy for colorectal liver metastases: a multicenter phase II study in patients resistant to first-line systemic chemotherapy.
assignment_turned_inProjectPartners:Centre Eugène Marquis, ICM-VAL D'AURELLE, Centre Hospitalier Universitaire de Toulouse, Centre René Gauducheau, Institut Gustave Roussy
Centre Eugène Marquis,
ICM-VAL D'AURELLE,
Centre Hospitalier Universitaire de Toulouse,
Centre René Gauducheau,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-2444
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Clinical phase II trial evaluating the efficacy of systemic Mesenchymal Stromal Cell (MSC) injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications (pelvic radiation disease, PRD) refractory to standard therapy. Acronym : PRISME (Pelvic Radiation dISease and MEsenchymal stromal cells)
assignment_turned_inProjectPartners:Groupe Hospitalier Pitié Salpétrière, Centre René Gauducheau, Groupe Hospitalier Lariboisière - Fernand Widal, Hôpital Saint-Antoine, Institut de Radioprotection et de Sûreté Nucléaire +6 partners
Groupe Hospitalier Pitié Salpétrière,
Centre René Gauducheau,
Groupe Hospitalier Lariboisière - Fernand Widal,
Hôpital Saint-Antoine,
Institut de Radioprotection et de Sûreté Nucléaire,
Hôpital Européen Georges Pompidou (HEGP) - AP-HP,
Hôpital Saint-Louis,
U1018, INSERM, UPS, UVSQ Institut Gustave Roussy – B2M,
Société Française de Bio Ingenierie Cellulaire et Tissulaire,
Groupe Hospitalier Henri Mondor - Albert Chenevier,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-7278
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Effect of a tailored program of physical activity and nutritional therapeutic education on clinical, psychological and sociological factors in breast cancer patients undergoing adjuvant treatment : « APAD » multicenter randomized controlled trial
assignment_turned_inProject2012 - 2015Partners:Centre Léon Bérard, Centre Eugène Marquis, CHUG, Hôpital Dupuytren, ICM-VAL D'AURELLE +5 partners
Centre Léon Bérard,
Centre Eugène Marquis,
CHUG,
Hôpital Dupuytren,
ICM-VAL D'AURELLE,
Institut Sainte Catherine,
Centre Oscar Lambret,
Centre Jean Perrin,
Université Montpellier,
Centre René Gauducheau
Funder: Institut National du Cancer Project Code: INCa-6162
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Optimisation pharmacocinétique et par imagerie de l’immuno-TEP préciblée avec l’anticorps bispécifique anti-ACE x anti-HSG TF2 et le peptide IMP-288 marqué au Gallium-68 pour l’imagerie des patients atteints de récidives de carcinome médullaire de la thyroïde. Pharmacokinetic and imaging optimization study of pretargeted immuno-PET using the anti-CEA x anti-HSG TF2 bispecific antibody and 68Ga-IMP-288 peptide in patients with recurrences of medullary thyroid carcinoma.
assignment_turned_inProject2010 - 2013Partners:CHU, CHU Nantes - Hôtel Dieu, Centre Hospitalier Universitaire d'Angers, ORGANISME NON ASSOCIE, Institut de Cancérologie de l'Ouest +3 partners
CHU,
CHU Nantes - Hôtel Dieu,
Centre Hospitalier Universitaire d'Angers,
ORGANISME NON ASSOCIE,
Institut de Cancérologie de l'Ouest,
HCL,
INSERM UMR892,
Centre René Gauducheau
Funder: Institut National du Cancer Project Code: INCa-2664
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
assignment_turned_inProjectPartners:Centre François Baclesse, Institut Curie, Centre Eugène Marquis, Centre René Gauducheau, Institut Paoli-Calmettes- (IPC) +10 partners
Centre François Baclesse,
Institut Curie,
Centre Eugène Marquis,
Centre René Gauducheau,
Institut Paoli-Calmettes- (IPC),
Centre Hospitalier de Mont-de-Marsan,
Centre Antoine Lacassagne,
Clinique Sainte Marguerite,
Centre Léon Bérard,
Hôpital Saint-Louis,
Institut Jean Godinot,
Hôpital Saint Joseph,
Hôpital Édouard Herriot,
Institut Gustave Roussy,
Institut de Cancérologie de l'Ouest
Funder: Institut National du Cancer Project Code: INCa-DGOS-7193
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Centre René Gauducheau

Centre René Gauducheau

73 Projects, page 1 of 15

Effect of a tailored program of physical activity and nutritional therapeutic education on clinical, psychological and sociological factors in breast cancer patients undergoing adjuvant treatment : « APAD » multicenter randomized controlled trial

GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.

Loading